The genome of severe acute respiratory coronavirus-2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has undergone a rapid evolution, resulting in the …
Z Sezer, STI Pavel, A Inal, H Yetiskin, B Kaplan… - Vaccines, 2024 - mdpi.com
Vaccine-induced immunity wanes over time and warrants booster doses. We investigated the long-term (32 weeks) immunogenicity and safety of a third, homologous, open-label …
Aim To evaluate anti-RBD IgG antibody levels and neutralizing antibody titers between the health care workers (HCWs) with breakthrough SARS-CoV-2 infection and controls …
In recent times, the SARS-CoV-2 virus has been observed to cause a serious threat to the world through its high permissive mutations by adapting itself to the host environment, which …
Antibody tests, widely used as a complementary approach to reverse transcriptase– polymerase chain reaction testing in identifying COVID-19 cases, are used to measure …
COVID-19, also known as the coronavirus, has had a major effect on the planet. As countries and governments seek to mitigate the spread out of the virus and protect their citizens, many …